Tagrisso 80 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F7VK4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,438
Award facts
- Contract value 100% obligated
- $12,438.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,438.15 to AmerSourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units). This firm fixed-price, competitively awarded contract has an ultimate completion date of February 13, 2026, with performance to be executed at the vendor's Conshohocken, Pennsylvania location. No set-aside designation was applied to this award. The delivery order was issued under AmerSourceBergen Drug Corp's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 31, 2031, serving as the prime vehicle for pharmaceutical and medical supply deliveries across the federal healthcare system.
This award represents a task order fulfillment under Cencora's comprehensive pharmaceutical supply contract, which supports military treatment facilities and federal healthcare programs globally. The delivery of Tagrisso, an oncology medication, exemplifies the vendor's role in supplying specialty pharmaceuticals across multiple therapeutic domains to the Department of Defense healthcare systems. As a recognized critical vendor in the federal pharmaceutical supply chain, Cencora and its subsidiary AmerSourceBergen Drug Corp continue to demonstrate capability in meeting government procurement requirements for essential medical commodities through open and competitive procurement processes.
Quick answers
Who was awarded contract SPE2DR26F7VK4?
SPE2DR26F7VK4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26F7VK4 worth?
The government has obligated $12,438 on SPE2DR26F7VK4.
Is contract SPE2DR26F7VK4 an order under another contract?
Yes. SPE2DR26F7VK4 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7VK4 competed?
The extent of competition for SPE2DR26F7VK4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award